High-Accuracy Gene Synthesis: Overcoming GC-rich Challenges
Learn how Tsingke achieves ultra-low mutation rates (<0.04‰) in synthetic genes, ensuring reliable results for even the most complex sequences.
IVD-grade Probes & Primers
The transition from research to approved in vitro diagnostics requires reagents of exceptional quality and traceability. Tsingke's IVD-grade oligonucleotides are produced under a certified quality management system, providing the consistency, documentation, and performance needed for your regulated diagnostic development.
Expression & Screening
Antibody expression and screening are critical to evaluating candidate performance. With optimized plasmid design, high-throughput cloning, and scalable expression systems, Tsingke provides the foundation for fast and reproducible antibody evaluation.
Preparing for the Next Pandemic
Beijing Tsingke Biotech Co., Ltd. is proud to announce our participation in the Cold Spring Harbor Asia Conference on Preparing for the Next Pandemic: Evolution, Pathogenesis, and Virology of Coronavi...
Tsingke Wins the 2024 Responsible Brand Award - Committed to Green Development and Social Responsibility
On January 9, 2025, Tsingke was honored with the prestigious "Responsible Brand Award," a recognition of the company’s long-term efforts in fulfilling its social responsibility. During the ...
Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions
Publication Date: Nov 19, 2025
Gene Synthesis
We offer fast, precise gene synthesis services including gene fragments, full-length constructs, and custom vector integration. All sequences are codon-optimized, cloned, and quality-verified using in-house reagents and platforms to support research, therapeutic, and industrial use cases.
Agricultural Biotech
Gene constructs, promoters, and genome editing tools for crop improvement, trait engineering, and plant-based expression systems in agricultural R&D.
Companion Diagnostics
Companion diagnostics (CDx) are essential for identifying patients who will benefit from specific targeted therapies. Tsingke partners with pharma and biotech companies to supply the high-quality primers, probes, and NGS panels required to develop, validate, and commercialize CDx assays.
Therapeutic Oligos
Therapeutic oligonucleotides, such as ASOs, siRNAs, and miRNAs, represent a powerful class of drugs that modulate gene expression with high specificity.
Tsingke provides comprehensive services for the design, synthesis, and modification of these molecules, supporting your efforts from early research to clinical development.
Crop Genomics & Trait Improvement
Modern agriculture relies on advanced genomics to improve yield, nutritional content, and resistance to pests and environmental stress. Tsingke provides researchers and agribiotech companies with gene synthesis, optimized for plant expression, accelerating the development of crops with desirable traits—from drought resistance to enhanced vitamin.
Therapeutic Development
Therapeutic development requires precision and quality. From bispecific antibody design to ADC linker oligos and GMP-grade production, Tsingke delivers scalable, compliant, and reliable solutions that accelerate translation into the clinic.(to Accelerate Clinical Translation)
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
